PerSe

Search documents
Alla ricerca di segni di vita su Marte | John Brucato | TEDxPadova
TEDx Talks· 2025-06-25 15:45
[Musica] Esiste la vita nello spazio. Sono secoli che ci poniamo questa domanda e ancora oggi non siamo riusciti a dare una risposta esaustiva. Cercare la vita nello spazio significa mettere insieme conoscenze che vengono dalla scienza, dalla tecnologia, dalla filosofia e perché no, farci anche ispirare dalla fantascienza.Oggi conosciamo più di 5.000% pianeti extrasolari e i grandi telescopi, le missioni spaziali ci stanno mostrando ambienti sempre più complessi. Quindi ipotizzare che esistano mondi abitabi ...
Tensions Over NASA’s Future
Bloomberg Technology· 2025-06-13 12:50
Many would say NASA needs to be going for the moon shots to use a better pun, but they should be going for extraordinary exploration. They perhaps shouldn't be funding well testing of, well, certain private companies engines. They shouldn't be actually beefing up in terms of manages.They'd be stripping layers. But is this going to the moon shots to. Well, I think that's kind of the question of of the moment right now.There's this fundamental tension of what an asset is supposed to be. You know, for years, f ...
Cordoba Minerals Announces Voting Results from Annual General Meeting of Shareholders
Newsfile· 2025-06-10 00:15
Core Points - Cordoba Minerals Corp. held its Annual General Meeting of Shareholders on June 9, 2025, where all nominated directors were elected [1] - Shareholders voted overwhelmingly in favor of the re-appointment of Deloitte LLP as the company's auditors for the upcoming year [2] - The company's stock option plan was re-approved, allowing for the issuance of shares not exceeding 10% of the company's issued and outstanding shares, pending final approval from the TSX Venture Exchange [3] Company Overview - Cordoba Minerals Corp. is focused on the exploration, development, and acquisition of copper and gold projects, including the Alacran Project in Colombia and a 51% interest in the Perseverance Copper Project in Arizona, USA [4]
数据可视化工具软件全解析:从入门到专业
Sou Hu Cai Jing· 2025-05-29 17:29
在大数据时代,数据可视化已成为企业和个人解读信息、洞察趋势的核心技能。面对海量数据,如何选 择合适的工具将其转化为直观的图表与仪表盘?本文将系统梳理七大类别30余款主流数据可视化工具, 助您精准匹配业务需求。 一、商业智能(BI)工具:企业级数据分析利器 1. Tableau(行业标杆) 作为全球领先的BI平台,Tableau提供从数据连接到高级分析的完整解决方案。其拖拽式操作界面支持 快速创建交互式仪表盘,独有的VizQL技术可自动优化可视化逻辑。典型案例包括沃尔玛使用Tableau实 现供应链动态监控,节省数百万美元库存成本。但每年999美元/用户的定价对中小企业构成门槛。 2. Microsoft Power BI(微软生态整合) 深度集成Office 365的Power BI,以每月9.9美元的订阅价格提供DAX公式、自然语言查询等高级功能。 某零售企业通过Power BI自动同步Azure数据库,将销售报告生成时间从3天缩短至实时更新。其局限性 在于复杂计算需要较强DAX编程能力。 3. Qlik Sense(关联引擎驱动) 采用内存计算技术的Qlik,能在10秒内处理千万级数据关联分析。某银行使用 ...
Semtech's Q1 Earnings Match Estimates, Revenues Increase Y/Y
ZACKS· 2025-05-28 15:40
Core Viewpoint - Semtech Corporation (SMTC) reported strong first-quarter fiscal 2026 earnings, with non-GAAP earnings of 38 cents per share matching the Zacks Consensus Estimate and revenues of $251.1 million exceeding expectations, indicating robust growth across all end markets, particularly in data centers [1][3][10]. Financial Performance - Non-GAAP earnings of 38 cents per share showed a significant improvement from 6 cents in the year-ago quarter, exceeding management's guidance of 37 cents [1][2]. - Revenues of $251.1 million surpassed the Zacks Consensus Estimate by 0.44% and increased by 22% year over year [3][10]. - Non-GAAP gross margin expanded to 53.5%, up 370 basis points year over year, while non-GAAP operating income surged 88.9% to $47.6 million [7]. Revenue Breakdown - Infrastructure market sales reached $72.8 million, accounting for 29% of net sales, with a year-over-year growth of 30% driven by data center demand [4]. - Industrial market sales were $142.8 million, representing 56.9% of net sales, up 24% year over year [4]. - High-end consumer market sales totaled $35.4 million, a 3% increase year over year, supported by strong design-in momentum for SurgeSwitch [5]. Product Line Performance - Signal Integrity sales were $73.5 million, up 26.1% year over year, making up 29.3% of net sales [6]. - Analog Mixed Signal & Wireless sales reached $90.6 million, a 20.3% increase year over year, accounting for 36.1% of net sales [6]. - IoT System and Connectivity sales were $86.9 million, reflecting a 19.9% year-over-year growth, comprising 34.6% of net sales [6]. Future Guidance - For Q2, Semtech expects net sales of $256 million (+/- $5 million), indicating a year-over-year rise of 18.5% [10]. - The company anticipates non-GAAP earnings of 40 cents (+/- 3 cents) per share, representing a year-over-year increase of 254.6% [12]. - Non-GAAP gross margin is expected to be around 53% (+/- 50 bps) for the upcoming quarter [11].
Pulmatrix Announces First Quarter 2025 Financial Results and Divestment Plan for Assets
Prnewswire· 2025-05-15 12:05
Core Viewpoint - Pulmatrix, Inc. is advancing its proposed merger with Cullgen, which is expected to close in June 2025, while divesting its clinical assets including the acute migraine candidate PUR3100 and its proprietary iSPERSE™ technology [1][3][2] Financial Performance - For the first quarter of 2025, Pulmatrix reported revenues of $0, a decrease of approximately $5.9 million compared to $5.9 million in the same period of 2024, primarily due to the completion of the PUR1900 Phase 2b clinical trial [11] - Research and development expenses decreased to less than $0.1 million, down approximately $3.5 million from $3.5 million in the first quarter of 2024, attributed to winding down the PUR1900 trial and other operational changes [12] - General and administrative expenses increased to $1.8 million, up approximately $0.2 million from $1.6 million in the first quarter of 2024, mainly due to costs related to the proposed merger [13] - As of March 31, 2025, the company's total cash and cash equivalents were $7.7 million, which is expected to be sufficient to fund operations through the anticipated merger closing [14] Product Pipeline and Technology - Pulmatrix's product pipeline includes PUR3100, an inhaled dihydroergotamine for acute migraine, which is Phase 2-ready following FDA acceptance of its IND application [7] - The company is also developing PUR1800, a Narrow Spectrum Kinase Inhibitor for chronic obstructive pulmonary disease, which has shown safety and tolerability in Phase 1b studies [6] - The iSPERSE™ technology enables the formulation of drugs into small, dense, and dispersible particles for efficient delivery to the lungs, enhancing therapeutic outcomes for various diseases [21][20] Merger Details - The merger agreement with Cullgen was initially reported on November 13, 2024, and amended on April 7, 2025, with the closing anticipated in June 2025, subject to certain conditions [3][4] - If successful, the merger will create a Nasdaq-listed company focused on targeted protein degradation technology, with three degrader programs in Phase 1 clinical trials [2]
安全用车透明消费 沃尔沃于柯鑫:关于“安全”我们一定标配
Zhong Guo Jing Ji Wang· 2025-05-07 08:51
在汽车工业的百年征程中,"安全"始终是衡量品牌高度的核心标尺。无论汽车企业在电动化、智能 化,以及"冰箱彩电大沙发"的赛道上如何内卷,当一切回归汽车作为"生命承载工具"这一本质的时候, 安全才是所有数字"0"前面的"1",赋予所有演进以重要价值。 与这种认知形成共鸣的,正是将安全镌刻于品牌基因的沃尔沃。"沃尔沃的品牌资产就是安全。在 造车理念上,这种安全已经根深蒂固,沃尔沃从整个工艺、研发上来讲,就是奔着安全走的。"沃尔沃 汽车大中华区销售公司总裁于柯鑫说道。 在这一理念持续深化下,沃尔沃发布消费透明承诺,消除用户在从新车销售到售后维修保养时因信 息不对称造成的疑虑和困惑,实现价格透明、产品透明以及流程透明。 提到沃尔沃汽车,很多人首先想到的大概就是"安全"这个标签。可以说,沃尔沃品牌与汽车安全早 已结下不解之缘,几乎成为消费者心中默认的"安全标杆"。 从1959年发明三点式安全带,到1991年推出侧撞保护系统(SIPS)、2018年推出对向车辆智能避让功 能,再到2024年推出Superset技术堆栈。梳理沃尔沃半个多世纪以来的安全技术革新,品牌逐渐构建起 立体的安全防护矩阵,从驾乘保护延伸至行人防护,从物 ...